Is there a role for stress CMR in stable chest pain with >60% predicted risk of coronary artery disease?
Sir,

The 2010 NICE guidelines1 on stable chest pain of recent origin have revolutionized its management. The management strategy is based on the estimated likelihood of coronary artery disease (CAD) using age, sex, risk factors and the character of chest pain. Functional imaging (for e.g. stress CMR/stress echo/myocardial perfusion scintigraphy) is only recommended in the group with predicted risk between 30% and 60%. The recently published CE-MARC study2 has shown that stress CMR is superior to SPECT in assessment of stable chest pain. In the CE-MARC study the overall X-ray angiography …